Detalhe da pesquisa
1.
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.
Blood
; 131(24): 2605-2616, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559479
2.
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 19(9): 1215-1228, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115596
3.
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
Blood
; 129(19): 2702-2705, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28325865
4.
Advances in the management of follicular lymphoma.
Curr Opin Oncol
; 24(6): 742-7, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22960557
5.
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
Genes Chromosomes Cancer
; 50(7): 546-58, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21500311
6.
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
Blood
; 114(17): 3615-24, 2009 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690339
7.
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
Leuk Lymphoma
; 60(3): 649-657, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30234404
8.
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.
Mol Med
; 14(11-12): 665-74, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19009014
9.
Risk stratification in chronic lymphocytic leukemia.
Semin Oncol
; 33(2): 186-94, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16616065
10.
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.
Drugs
; 76(6): 639-46, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27052260
11.
Microenvironmental influences and antigenic stimulation in chronic lymphocytic leukemia.
Onkologie
; 32(10): 550-1, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19816069
12.
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.
PLoS One
; 8(8): e72107, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24009671
13.
High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
Leuk Lymphoma
; 54(8): 1652-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23189934
14.
Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
Immunotherapy
; 1(6): 1015-24, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20635916
15.
Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Leuk Lymphoma
; 53(1): 169-72, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21812535
16.
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
Blood
; 107(5): 2090-3, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322480
17.
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
J Clin Oncol
; 24(6): 969-75, 2006 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16418492
18.
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Blood
; 100(4): 1410-6, 2002 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12149225